Summary

Hold, $545 target: the price pays for Azure's growth but not the FY28 margin step-down

InitiationBy Penmark Team
MSFTHold$545.00+3%
Page 1 of 16
Equity research | Initiation of coverage | United States
Software and cloud infrastructure | Coverage: Initiated | Published 8 November 2026, 09:00 ET
Penmark Research Team | research@penmarkresearch.com
Microsoft Corporation (Nasdaq: MSFT)

Hold, $545 target: the price pays for Azure's growth but not the FY28 margin step-down

Rating
Initiation
Hold
12-month target
$545
Price, 6 Nov
$530.61
Price return
+2.7%
Total return
+3.5%
Bull case
$681
Bear case
$272

We initiate at Hold with a $545 target, a +3.5% total return. Microsoft sells cloud infrastructure (Azure, 31% of FY26 revenue), Microsoft 365 subscriptions, Windows, Xbox and search. The market is right on Azure growth and light on its cost: our weighted value is $503, 5.2% below the price.

  • Azure stays above 40% in FY27, so revenue lands within 1% of consensus. FY27E revenue is $395.0bn (+19.0%) against $399.0bn; backlog (RPO) is $677bn, +73%.
  • Depreciation cuts FY28E operating margin to 43.7%, against about 47% implied by consensus. D&A rises from $38.5bn to $82.0bn; FY28E EPS is $21.90 against $24.14, worth $54 a share.
  • The price already pays for the AI build. At 24.7x forward EPS against our 22.55x target multiple, the price implies Azure growth 1.2pts higher every year.

What the market is missing. Revenue is close ($470bn against $477bn in FY28E); the gap is cost. About $350bn of FY26-FY27 capex, mostly short-lived, hits the income statement from FY28.

Catalysts. OpenAI round close (Dec 2026); FQ2 results (late Jan 2027, Azure guided +49-50%); FQ4 call with the FY28 outlook (late Jul 2027).

Valuation and target. DCF (WACC 8.9%, terminal growth 3.0%) gives $489; P/E at 22.55x plus the OpenAI stake gives $487. Bear $272 (20%), base $489 (50%), bull $681 (30%) weight to $503; upside to downside is 0.6x.

Risks. A 1pt lower discount rate lifts weighted value to $619 (Buy), 1pt higher cuts it to $422 (Sell); conviction is low. Against us: 43 of 49 analysts rate it Buy.

Exhibit 1: EPS grows 12% a year from FY27E to FY29E, but FCF yield stays below 2% until FY29E
Year to 30 JunFY25AFY26AFY27EFY28EFY29E
Revenue ($bn)281.7331.8395.0469.8547.2
Growth y/y14.9%17.8%19.0%18.9%16.5%
EBITDA ($bn)157.9193.8240.9287.5336.5
Margin56.1%58.4%61.0%61.2%61.5%
Net income ($bn)101.8133.7145.6162.2180.6
EPS, diluted ($)13.6417.9519.5521.9024.67
Growth y/y15.6%31.6%8.9%12.0%12.7%
Free cash flow ($bn)71.667.041.165.5105.5
At $530.61FY25AFY26AFY27EFY28EFY29E
P/E38.9x29.6x27.1x24.2x21.5x
EV/EBITDA25.3x20.6x16.6x13.9x11.9x
P/B11.5x8.9x7.1x5.9x5.1x
FCF yield1.8%1.7%1.0%1.7%2.7%
Dividend yield0.63%0.69%0.73%0.78%0.85%
ROE33.3%34.0%29.1%26.5%25.3%
Net debt / EBITDA−0.33x−0.19x−0.13x−0.07x−0.03x
P/E at our $545 target40.0x30.4x27.9x24.9x22.1x

Source: Company filings (A); Penmark Research model (E). FY25A-FY26A EPS is GAAP incl. OpenAI; FY27E onward excludes OpenAI gains and losses. FCF is cash from operations less cash capex. Net debt excludes finance leases; ROE on average equity. Multiples at the 6 Nov 2026 price, except the last row.

Base value is $489 and weighted value $503: $150 of upside against $259 of downside leaves a Hold

Exhibit 3: At 12 months the weighted value is the $545 target
$200$300$400$500$600$700$800Jan-26Jul-26Jan-27Jul-27ActualEstimatesPrice $531Bull $737 (+39%)Base $530 (−0.1%)Bear $294 (−45%)Target $545 (+3%)

Source: Yahoo Finance closes (history); Penmark Research model (scenarios)

Scenarios and price target basis
Bull$681+28.3%30% prob.

Azure +47% FY27, +40% FY28; capex 44% of revenue in FY28; OpenAI $1.25tn. FY28E EPS $24.47.

Base$489−7.8%50% prob.

Azure +44.5% FY27, +35% FY28; capex 52% then 47.5%; OpenAI $852bn. FY28E EPS $21.90.

Bear$272−48.8%20% prob.

OpenAI trims commitments; Azure +24% FY28; costs fixed; OpenAI $500bn. FY28E EPS $18.21.

Probability-weighted value$503−5.2%
Upside to downside0.6x$150 up / $259 down
Exhibit 4: Revenue +19% in FY27E; EBIT margin falls to 43.7%
Income, $bnFY25AFY26AFY27EFY28EFY29E
Revenue281.7331.8395.0469.8547.2
Gross profit193.9225.5259.3294.8332.7
EBITDA157.9193.8240.9287.5336.5
EBIT128.5155.2183.6205.5229.7
Fin. and other−4.910.7−1.6−2.8−4.0
Tax−21.8−32.2−36.4−40.5−45.1
Net income101.8133.7145.6162.2180.6
Tax rate17.6%19.4%20.0%20.0%20.0%
Exhibit 5: Cash capex takes 81% of operating cash flow in FY27E
Cash flow, $bnFY25AFY26AFY27EFY28EFY29E
Net income101.8133.7145.6162.2180.6
D&A29.438.557.382.0106.8
SBC and other10.315.513.416.018.6
Working capital−5.3−4.95.26.16.3
Op. cash flow136.2182.9221.5266.3312.3
Cash capex−64.6−115.9−180.4−200.8−206.8
Free cash flow71.667.041.165.5105.5
Payouts−42.5−48.7−42.1−71.1−107.2
Exhibit 6: PP&E more than doubles to $734bn by FY29E
Balance, $bnFY25AFY26AFY27EFY28EFY29E
Cash, invest.94.676.887.075.366.4
Receivables69.980.996.3114.5133.4
PP&E, net205.0313.1464.1608.2733.8
Total assets619.0758.4941.11,100.01,244.6
Debt43.240.356.156.156.1
Unearned rev.67.375.790.1107.2124.8
Net debt−51.4−36.5−30.9−19.2−10.4
Equity343.5442.4559.3666.3758.3
Exhibit 7: Azure is 37% of FY27E revenue, up from 26%
Per share, KPIsFY25AFY26AFY27EFY28EFY29E
Dil. shares (m)7,4657,4537,4467,4057,318
EPS ($)13.6417.9519.5521.9024.67
DPS ($)3.323.643.854.164.49
FCF/share ($)9.598.995.528.8414.42
BVPS ($)46.0159.3675.1189.99103.63
Azure ($bn)72.6101.9147.3198.9252.5
M365 ($bn)84.6100.3118.4137.3156.5
Azure % of rev.25.8%30.7%37.3%42.3%46.2%

Source: Company filings (A); Penmark Research model (E). Exhibit 3 rolls scenario values to 6 Nov 2027 at the cost of equity less dividend yield. Years end 30 June. FY25A-FY26A net income is GAAP incl. OpenAI; FY27E on excludes it. Cash capex and net debt exclude finance-leased assets. Bold = totals and thesis lines; italic = ratios.

Returns stay above 24% ROE, but margins and FCF are where we differ from consensus: FY28E EPS is 9.3% lower

Exhibit 8: EBIT margin falls from 46.8% to 42.0% by FY29E as D&A reaches 19.5% of sales
Growth, margins (%)FY25AFY26AFY27EFY28EFY29E
Growth y/y
Sales14.9%17.8%19.0%18.9%16.5%
EBITDA–22.7%24.3%19.3%17.0%
EBIT17.4%20.8%18.3%11.9%11.8%
EPS15.6%31.6%8.9%12.0%12.7%
DPS10.7%9.6%5.8%8.0%8.0%
Margins and intensity
Gross margin68.8%67.9%65.7%62.8%60.8%
EBITDA margin56.1%58.4%61.0%61.2%61.5%
EBIT margin45.6%46.8%46.5%43.7%42.0%
FCF margin25.4%20.2%10.4%13.9%19.3%
D&A / sales10.4%11.6%14.5%17.5%19.5%
Capex / sales22.9%34.9%45.7%42.7%37.8%
Exhibit 9: ROE eases from 34% to 25% while P/E on FY28E is 24.2x at the price
Ratios and valuationFY25AFY26AFY27EFY28EFY29E
Returns and leverage
ROE33.3%34.0%29.1%26.5%25.3%
ROA18.0%19.4%17.1%15.9%15.4%
ROCE33.2%32.2%29.8%28.4%28.2%
Net debt / equity−15.0%−8.3%−5.5%−2.9%−1.4%
Net debt / EBITDA−0.33x−0.19x−0.13x−0.07x−0.03x
Valuation at $530.61
P/E38.9x29.6x27.1x24.2x21.5x
EV/EBITDA25.3x20.6x16.6x13.9x11.9x
P/B11.5x8.9x7.1x5.9x5.1x
FCF yield1.8%1.7%1.0%1.7%2.7%
Dividend yield0.63%0.69%0.73%0.78%0.85%
P/E at our $545 target40.0x30.4x27.9x24.9x22.1x

Source: Company filings (A); Penmark Research model (E). ROE and ROA on average balances; ROCE is EBIT over equity plus debt; net debt excludes finance leases. FY25A-FY26A EPS growth is GAAP incl. OpenAI. Multiples at the 6 Nov 2026 share price, except the last row.

Exhibit 10: FY28E EPS is 9.3% below consensus; revenue is only 1.5% below
$bn / $ per shareFY27EFY28E
Revenue ($bn)
Penmark estimate394.97469.82
Consensus398.96477.21
Prior-year period331.84394.97
Diff. vs consensus−1.0%−1.5%
Growth y/y (Penmark)+19.0%+18.9%
EPS excl. OpenAI ($)
Penmark estimate19.5521.90
Consensus20.0224.14
Prior-year period17.2819.55
Diff. vs consensus−2.3%−9.3%
Growth y/y (Penmark)+13.1%+12.0%

Source: Company filings; consensus per 247 Wall St (EPS, 5 Nov 2026) and Chartmill (revenue, Oct 2026); Penmark Research model. Prior-year EPS is the sum of reported quarterly EPS excluding OpenAI for FY26A.

Exhibit 11: EPS grows 12% a year from FY27E to FY29E; consensus is 2% above us in FY27E and 10% in FY28E
Consensus$0$5$10$15$20$25FY24AFY25AFY26AFY27EFY28EFY29EActualEstimates$24.67

Source: Company filings (A), Penmark Research model (E), 247 Wall St consensus ($20.02 FY27E, $24.14 FY28E). FY24A-FY26A are GAAP incl. OpenAI; FY27E onward excludes it. EPS by year in Exhibit 10.

Four dated events decide the call, and at 27.7x trailing earnings the stock is one deviation below its own average

Exhibit 12: MSFT trades at 28% above the peer median P/E on twice the margin
Latest, 6 Nov 2026MSFTPeersDiff.
Valuation
P/E, next 12m24.7x19.3x+28%
P/E, platform peers24.7x22.6x+10%
Returns and growth
Operating margin49.8%25.8%+24.0pp
ROIC25.7%16.0%+9.7pp

Source: Motley Fool, Zacks (P/E, 2-6 Nov 2026); Company filings, key metrics (latest quarter); Penmark Research. Eight peers; platform peers are Alphabet, Amazon, Meta, Apple. Difference in % for multiples, pp for ratios.

Exhibit 15: Trailing P/E is 27.7x, 1.0 standard deviation below its 4.9-year average of 32.5x
20x25x30x35x40x45x2022202320242025202627.7x

Source: Yahoo Finance closes; reported diluted EPS (GAAP, incl. OpenAI), Dec 2021 to 6 Nov 2026; Penmark Research. Dashed line = mean 32.5x; shading = ±1 and ±2 standard deviations.

Exhibit 13: Four dated catalysts, next nine months
  • Dec 2026OpenAI round closes; our $852bn basis is 32% below the $1.25tn first close ($13 a share, base re-run).
  • Late Jan 2027FQ2 results: Azure guided +49-50%; we model FY27E +44.5%. Capex guide over $50bn.
  • Jan-May 2027Texas session on data-centre moratoria: +$3.50 a share in the bull case if supply is capped; permit freezes cost $2.50 in the bear case.
  • Late Jul 2027FQ4 call and FY28 outlook: we expect 43.7% operating margin, consensus about 47%.

Source: Company calendar; Penmark Research model.

Exhibit 14: Depreciation is the largest risk to value: $54 a share in the DCF, $18 in the 12-month P/E bridge
  • Depreciation catch-up. D&A reaches $82bn in FY28E on $350bn of short-lived capex. Likelihood High; −$17.80/share (P/E bridge).
  • OpenAI trims commitments. 11% of FQ1 revenue; $7.2bn receivable. Likelihood Low; −$3.50/share.
  • Permit freezes delay capacity. Third-party GPU capacity slips beyond H2 FY27. Likelihood Medium; −$2.50/share.
  • Azure stays near 40% in FY28 (runs against Hold). Fleet efficiency lifts capacity. Likelihood Medium; +$7.50/share.
The thesis is invalidated ifFQ4 FY27 guidance (late Jul 2027) implies FY28 operating margin above 46%; that lifts us to the top of Hold.

Source: Penmark Research model; next-twelve-month P/E bridge, which understates long-run effects.

Exhibit 16: P/E rises with ROIC but weakly (R² 0.23); MSFT sits close to the fitted line
0x10x20x30x40x0%20%40%60%80%Forward P/E (NTM)ROIC, latest quarterMSFTGOOGLAMZNMETAAAPLCRMNOWADBER² 0.23, n=8

Source: Motley Fool, Zacks (P/E, 2-6 Nov 2026); company filings, key metrics (ROIC); Penmark Research. Seven uncovered peers; Oracle has no ROIC.

The stock trades on operating margin (0.64 correlation), and our FY28 margin is 3 points below the Street

Exhibit 17: Operating margin and the share price move together (correlation 0.64 over eight quarters)
Share price at quarter end ($, left axis)Operating margin (%, right axis)$350$400$450$500$55044454647484950FQ2 FY25FQ3 FY25FQ4 FY25FQ1 FY26FQ2 FY26FQ3 FY26FQ4 FY26FQ1 FY27

Source: Company filings; Yahoo Finance quarter-end closes; Penmark Research. Latest quarter (FQ1 FY27): operating margin 49.8%, price $513. Eight quarters is a small sample.

Exhibit 18: Azure revenue is up 91% in seven quarters to $33.2bn
$0$10$20$30$40FQ2FY25FQ3FY25FQ4FY25FQ1FY26FQ2FY26FQ3FY26FQ4FY26FQ1FY27$17.3$18.5$20.7$22.4$24.1$26.0$29.4$33.2

Source: Form 8-K, 2 Sep 2026 (restated FY27 structure); Form 10-Q FQ1 FY27

Exhibit 19: Quarterly D&A is up 81% in seven quarters; revenue is up 33%
$0.0$2.5$5.0$7.5$10.0$12.5FQ2FY25FQ3FY25FQ4FY25FQ1FY26FQ2FY26FQ3FY26FQ4FY26FQ1FY27$6.7$7.3$7.9$8.6$9.1$10.1$11.2$12.1

Source: Company filings and earnings calls, FQ2 FY25 to FQ1 FY27

Exhibit 20: We are 1.0% below consensus on FY27E revenue and 1.5% below on FY28E
Our estimateConsensusPriorFY27E revenueFY28E revenue$395.0bn$469.8bn

Source: Chartmill, TIKR (consensus, Oct 2026, before the FQ1 print); Penmark Research model. Prior year = last reported or forecast fiscal year.

Exhibit 21: Contracted backlog (RPO) is $677bn, up 73% on a year
$0$200$400$600$8002Q253Q254Q251Q262Q263Q264Q261Q27$298$315$368$392$625$627$678$677

Source: Earnings calls and Form 10-Q, FQ2 FY25 to FQ1 FY27 (fiscal quarters)

Exhibit 22: A 1-point lower discount rate or the bull case gives a Buy; a higher discount rate or beta gives a Sell
Rating moveTestValue / shareReturn to valueRating (return-to-value rule)
UpgradeDiscount rate 1 point lower$618.50+16.6%Buy
UpgradeBull case (Azure +40% in FY28)$680.75+28.3%Buy
HoldBase case alone$489.40−7.8%Hold
DowngradeBeta at high end (1.10)$463.49−12.7%Sell
DowngradeDiscount rate 1 point higher$422.12−20.5%Sell

Source: Penmark Research model (robustness tests). Discount-rate and beta rows are probability-weighted values against the $530.61 price on 6 Nov 2026 (base $503.28); base and bull rows are single-case DCF values. For the base case alone, a 1pt move in discount rate gives $601 and $410 (Exhibit 42).

The call rests on one debate worth $54 a share: whether depreciation pulls FY28 margin toward 44%

FY27-28 revenue is not in dispute; FY29 revenue is (debate 2). We are 1.0% and 1.5% below consensus on FY27E and FY28E revenue. The gap is cost: consensus FY28 EPS of $24.14 implies a 47% margin; ours is $21.90 at 43.7%.
Exhibit 23: Five debates frame the call; the four we value separate $489 from $531, and margin is $54
DebateMarket viewPenmark viewEvidenceWhat changes our viewResolves
1. FY28 margin and the D&A catch-upFY28 EPS $24.14, operating margin near 47%FY28 EPS $21.90, margin 43.7%D&A $12.1bn in FQ1, +41% y/y; FY26-27 capex about $350bn, 72% short-livedFY28 outlook implying margin above 46%Late Jul 2027 (FQ4 call)
2. Azure durability beyond FY27FY29 revenue $581bnFY29 revenue $547bnAzure +48% in FQ1; guide +49-50%; RPO $677bn, +73%; capacity-boundAzure above 40% in FY28 with capacity addedLate Jan 2027 (FQ2)
3. Value of the OpenAI stake$1.25tn, Nov 2026 round$852bn, Mar 2026 round24% stake worth $27.46 a share at $852bn; OpenAI is 11% of FQ1 revenueRound closing at or above $1.25tnDec 2026
4. Required return on the AI buildEquity risk premium 4.93%, the premium that reconciles the market-view cash flows of debates 1-3 to the priceEquity risk premium 4.23% on our base-case cash flowsOn our base-case cash flows the price implies WACC of 8.46% against our 8.88%Capex update showing returns above cost of capitalLate Jan 2027 (FQ2)
5. Copilot monetisationSeat plus consumption pricing lifts Microsoft 365 cloudMicrosoft 365 cloud +18% FY27E, +16% FY28EFQ2 guide about 19% vs 17% in FQ1; credit-consuming Copilot customers +75% q/q; paid seats +5%, the series lowMicrosoft 365 cloud above 19% growthFQ2-FQ4 FY27

Source: Company filings and calls; Penmark Research model (Market Check, debate re-runs, base case).

Exhibit 24: Moving to the market's view on each debate takes value from $489 to $596; the risk premium then takes it to $531
Our view (start of step)Market view (end of step)1 FY28 margin2 Azure FY28-293 OpenAI stake4 Risk premium$489$543$543$583$583$596$531$596

Source: Penmark Research model (debate re-runs, applied in sequence, base case); $ per share

Exhibit 25: Three of four debates resolve by late January 2027
Dec 2026OpenAI roundDebate 327 JanFQ2 resultsDebates 2, 4AprFQ3 resultsCapacityJulFQ4, FY28 outlookDebate 1

Source: Company calendar; Penmark Research

What it means for valueDebate 1 is the only one worth over $50 a share. A FY28 outlook with margin above 46% moves base value toward $543 and the rating to the top of the Hold range.

Azure and Microsoft 365 cloud are 61% of revenue and all of the FY27E growth, at a 47% operating margin

Microsoft sells consumption and subscriptions. Azure (billed on usage) and Microsoft 365 cloud (billed per seat, annually in advance) made up $202bn of $332bn FY26A revenue. Cost to deliver is rising as capex becomes depreciation.
Exhibit 26: Of every $100 of FY26A revenue, $47 became operating income; Azure revenue was $31
Azure$101.9bnMicrosoft 365 cloud$100.3bnServer and licensing$37.3bnSearch and advertising$24.8bnXbox$21.8bnOther$45.7bnRevenue$331.8bnCost of revenue$106.4bnGross profit$225.5bnR&D$35.6bnSales, marketing, G&A$34.7bnOperating profit$155.2bn

Source: Company filings, FY26A (year to 30 Jun 2026), $bn; Other is Industry solutions, Frontier and support, Windows OEM and devices

Exhibit 27: FY27E revenue of $395.0bn is led by Azure at +44.5% and Microsoft 365 cloud at +18%
FY26A base$101.9bnGrowth+44.5%Azure$147.3bn, 37% of revenueFY26A base$100.3bnGrowth+18.0%Microsoft 365 cloud$118.4bn, 30% of revenueDevices and Consumer$63.3bn, −0.6%Server, industry, support$66.0bnAll other lines$129.3bn, 33% of revenueRevenue FY27E$395.0bn, +19.0%

Source: Company filings (FY26A); Penmark Research model (FY27E); highlighted boxes are the drivers we forecast

Exhibit 28: Cloud demand outruns supply: Azure grew 48% and backlog is up 73%
48%FQ1 FY26: 40%Azure growth, FQ1 FY27$677bn+73% on a yearCommercial RPO, 30 Sep2026$63.9bn+30% on a yearMicrosoft Cloud revenue,FQ166%FQ4 FY26: 65%Microsoft Cloud grossmargin, FQ15%FQ1 FY26: 7%Microsoft 365 seat growth,FQ1

Source: Earnings calls and Form 10-Q, FQ1 FY27 (quarter to 30 Sep 2026)

The stock trades on the multiple, not on earnings: two drivers, FY28 margin and Azure growth, explain it

EPS grew 36% in a year and the price rose 7%. The trailing P/E fell from 35.4x to 27.7x. What moves the stock is how much of the cost of the AI build lands in margin, and how long Azure stays above 40%.
Exhibit 29: Two drivers explain the stock; the market pays $54 a share more than we do for one of them
DriverWhat moves the stockTests confirmedMarket vs our valueDebateNext number
FY28 operating marginMargin and price move together (0.64); the multiple fell 22% in a year while EPS rose 36%Return decomposition; quarterly margin correlation$543 at consensus margin vs $489 ours: $54, 11%1Late Jul 2027: FY28 outlook; we expect 43.7%, consensus about 47%
Azure growthJul 2026 +15.5% on Azure +43%; Azure revenue is up 91% in seven quartersEvent-day reaction; sensitivity$583 at consensus FY29 revenue vs $543: $40, 7%227 Jan 2027: FQ2 Azure +49-50% guided; we model FY27E +44.5%

Source: Yahoo Finance; company filings; Penmark Research model (Market Check, debate re-runs, applied in sequence).

Exhibit 30: Nine straight EPS beats, six falls the next day: the size of the beat does not set the move
ResultsEPS beatNext dayvs S&P
Oct 24+6.1%−6.1%−4.2pp
Jan 25+3.5%−6.2%−6.7pp
Apr 25+7.4%+7.6%+7.0pp
Jul 25+8.1%+3.9%+4.3pp
Oct 25+12.7%−2.9%−1.9pp
Jan 26+5.7%−10.0%−9.9pp
Apr 26+4.8%−3.9%−5.0pp
Jul 26+11.8%+15.5%+13.8pp
Oct 26+3.6%−0.2%+0.1pp

Source: Yahoo Finance closes, reported against estimated EPS, Oct 2024 to Oct 2026; correlation of beat and move 0.54, driven by Jul 2026 (+15.5%).

Exhibit 31: Over one year EPS grew 36% but the multiple fell 22%, leaving the price up 7%
$0$200$400$600$8006 Nov 2025EPS growthP/E change6 Nov 2026$497+$180−$146$531

Source: Yahoo Finance closes; trailing P/E on reported diluted EPS (incl. OpenAI), 35.4x to 27.7x; multiplicative split, $ per share

Exhibit 32: Market and sector explain a third of weekly price variance; two thirds is company-specific
Weekly returns, 158 weeksR²
S&P 500 alone0.34
Technology sector ETF (XLK) alone0.34
S&P 500 and XLK together0.36

Source: Yahoo Finance weekly closes, Nov 2023 to 6 Nov 2026; Penmark Research regression.

Exhibit 33: Two common explanations fail: EPS beats and the index do not explain the stock
Candidate testedResultVerdict
Size of the EPS beatBeat nine times; fell after six; Jan 2026 fell 10.0% on a 5.7% beatDropped
Market and sector directionR² 0.34 to 0.36; leaves two thirds unexplainedContext, not a driver

Source: Yahoo Finance; Penmark Research. Limits: nine results and three years of weekly data; earnings-call question counts were not tested.

We forecast 19% revenue growth in FY27E, in line with guidance; depreciation then cuts margin by 2.7 points in FY28E

Revenue is the easy part. Azure grows 44.5% in FY27E and 35% in FY28E; Microsoft 365 cloud 18% and 16%. Capex of about $350bn across FY26-FY27 (72% short-lived, six-year life) lifts D&A from $38.5bn to $82.0bn by FY28E.
Exhibit 34: Azure's share of cloud infrastructure spend fell 1 point to 19% while the market grew 55%
Q3 2025Q3 20260102030AWSAzureGoogle Cloud292620191316

Source: Synergy Research Group via CRN, Q3 2026 (share of $168bn, % of spend); share is for a broader scope than company-reported Azure revenue

Exhibit 35: Capex plateaus near $230bn from FY28E, so D&A reaches $82bn in FY28E and $151bn by FY31E
Capex incl. finance leases ($bn)D&A ($bn) (right)$0$50$100$150$200$250$25$50$75$100$125$150$175FY26AFY27EFY28EFY29EFY30EFY31EActualEstimates

Source: Company filings (A); Penmark Research model (E), $bn; capex includes finance-leased assets

Exhibit 36: Operating margin falls from 46.8% to 43.7% in FY28E; consensus EPS implies about 47%
Consensus01020304050FY25AFY26AFY27EFY28EFY29EFY30EActualEstimates41.1

Source: Company filings (A); Penmark Research model (E); consensus-implied margin of 47.0% from EPS $24.14 on revenue $477bn (247 Wall St, Chartmill, 5 Nov 2026). Margins: 45.6%, 46.8%, 46.5%, 43.7%, 42.0%, 41.1%.

Exhibit 37: Our gap to consensus is mostly cost, not demand: FY28E EPS is 9.3% lower
LineConsensusPenmarkGap
Revenue FY27E$398.96bn$394.97bn−1.0%
Revenue FY28E$477.21bn$469.82bn−1.5%
Revenue FY29E$581.38bn$547.17bn−5.9%
EPS FY27E$20.02$19.55−2.3%
EPS FY28E$24.14$21.90−9.3%

Source: Chartmill, 247 Wall St, TIKR (consensus, Oct-Nov 2026; revenue before the FQ1 print); Penmark Research model.

Exhibit 38: Every FY27 guide is met by our forecast, with margin inside the range, 0.2 points above the midpoint
Management guidancePeriodGuidedPenmark modelInside?
RevenueFQ2 FY27$96.0-97.1bn$96.7bnYes
Revenue growthFY27Double digits+19.0%Yes
Operating margin, down under 1 point from 46.8%FY2745.8-46.8%46.5%Yes
Operating expense growthFY274-9%7.9%Yes
Windows OEM and devicesFY27−16% to −19%−18%Yes
Free cash flow, reported basisFY27Positive$41.1bnYes

Source: Q4 FY26 call (29 Jul 2026) and Q1 FY27 call (28 Oct 2026); Penmark Research model (Guidance).

Value of $503 a share is 5% below the price: DCF and P/E agree at $489 and $487, and the weighted value sets a $545 target

Exhibit 39: The base case sits below the $530.61 price; four upside tests clear it: bull, 1pt lower discount rate, Azure +2pts and the Street high
DCF, bear to bullDiscount rate ±1ptAzure growth ±2ptsCost of revenue ±1ptStreet targets, low to high$200$400$600$800$1000$271.80$680.75$410.47$601.44$434.32$558.86$476.46$502.34$440.00$870.00Price $530.61

Source: Penmark Research model (DCF value per share at 6 Nov 2026; ±1pt rows hold terminal growth at 3.0%); Street targets 247 Wall St, tickernerd, Oct-Nov 2026. Our 12-month target of $545.07 is the weighted value ($503.28) rolled forward.

Exhibit 40: Only 30% of the weight sits above the $531 price; the weighted value is $503
$0$200$400$600$800$271.80$489.40$680.75Bear20%Base50%Bull30%Weighted $503.28

Source: Penmark Research model, DCF full re-runs at 6 Nov 2026; probabilities are analyst assumptions fixed before valuation

Exhibit 41: DCF and P/E agree within 0.5%; the $545 target rolls the weighted value forward
StepValue / share
DCF, base case (primary)$489.40
P/E cross-check: 22.55x on $20.38 EPS plus stake$487.08
Probability-weighted value (20/50/30)$503.28
Return to value against $530.61−5.2%
12-month target (value × (1 + 9.0% cost of equity − 0.7% yield))$545.07
Total return to target, with dividend+3.5%

Source: Penmark Research model (Valuation, Market Check). Hold on the model rule (return to value inside ±10%); the +3.5% total return to target is also inside ±10%.

Exhibit 42: Base-case value runs from $404 to $626 across discount rate and growth; the price needs the top-left
$581$591$601$613$626$525$532$540$549$558$478$484$489$496$502$439$443$447$451$456$404$407$410$414$418Terminal growth2.50%2.75%3.00%3.25%3.50%Discount rate7.88%8.38%8.88%9.38%9.88%

Source: Penmark Research model (Scenarios), base-case DCF value per share; cash flows held. Weighted-value sensitivity is $619 / $422 (Exhibit 22).

Exhibit 43: The price needs 4.35% terminal growth, an 8.46% WACC or Azure 1.2pts faster
What the $530.61 price impliesOur modelPrice implies
Terminal growth3.00%4.35%
Discount rate (WACC)8.88%8.46%
Azure growth, every forecast yearBase path+1.2pts
P/E on next-12-month EPS22.55x24.69x

Source: Penmark Research model (Market Check, reverse DCF; each solve plugs back to $530.61).

The next nine months bring five dated tests; the FY28 outlook in July 2027 is the one that can end the Hold

Exhibit 44: Five dated events in the next nine months decide whether the rating moves
Dec 2026OpenAI round closes$852bn basis vs $1.25tn27 Jan 2027FQ2 FY27 resultsAzure guide +49-50%;capex over $50bnApr 2027FQ3 FY27 resultsThird-party GPU capacity,H2 FY27May 2027Texas session endsData-centre moratoriaJul 2027FQ4 call, FY28 outlookMargin 43.7% vs about47%

Source: Company calendar; Penmark Research model (Thesis catalysts)

Exhibit 45: Upside catalysts shown are worth $23 a share in total, downside catalysts $26; the FY28 outlook alone is $17.80 on this bridge ($54 in the DCF)
CaseCatalystTiming$ / shareProbabilityIn consensus?
BullAzure above 45% in FY27, near 40% in FY28FQ2, FQ3 prints+7.5035%Partly
BullCopilot and usage billing lift Microsoft 365 cloudFQ2-FQ4+5.0040%Partly
BullIn-house models cut inference costThrough FY27+7.0030%Partly
BullState moratoria slow capexJan-May 2027+3.5030%Not priced
BearDepreciation catch-up: D&A of about $82bn in FY28Late Jul 2027−17.8070%Not priced
BearOpenAI trims or delays commitmentsFY27 H2−3.5020%Not priced
BearPermit freezes cap H2 FY27 AzureFQ3 print−2.5035%Partly
BearWindows OEM falls on memory-driven PC pricesFQ2-FQ3−1.8030%Partly

Source: Penmark Research model (Thesis catalysts); impacts use the next-twelve-month P/E bridge and understate long-run effects. Not every catalyst is shown.

Exhibit 46: The thesis ends if the FY28 outlook shows operating margin above 46%; that lifts us to the top of Hold
Risk to the HoldDirectionMechanismLikelihood
Depreciation hits FY28 marginDownside$350bn of short-lived capex; EPS −$2.00 in FY28High
OpenAI concentrationDownside11% of FQ1 revenue; $7.2bn receivableLow
Fleet efficiency frees capacityUpsideAzure near 40% in FY28; value $681 in the bull caseMedium
Lower discount rateUpsideOne point lower gives $618.50, a BuyMarket-driven

Source: Penmark Research model (Thesis, Market Check). Regulatory, legal and key-person risks are not separately valued in the model.

Ownership is index-heavy and the Street is 88% Buy; short interest is falling

Positioning is crowded on the long side. No analyst rates the stock Sell and mean target is $633. That leaves little room for upgrades; our Hold is a call on the multiple, not on a broken business.
Exhibit 47: Ten institutions hold 2.6bn shares worth $967bn; Vanguard and BlackRock hold 18%
VanguardBlackRockState StreetGeodeFMRJPMorganMorgan StanleyNorges BankInvescoT. Rowe Price$273bn$227bn$118bn$71bn$69bn$50bn$48bn$38bn$37bn$36bn

Source: SEC Form 13F filings, period 30 Jun 2026; reported holders cover 73.7% of shares outstanding; value in $bn

Exhibit 48: Short interest fell from 92m shares in July to 66m in October, 0.9% of shares
Short position (m shares)60708090100Jul-26Aug-26Sep-26Oct-2666

Source: FINRA equity short interest, 30 Jun to 15 Oct 2026; y-axis in m shares; days to cover 3.2 at 15 Oct

Exhibit 49: The Street mean target of $633 is 16% above ours of $545 and 19% above the price
Street low $440Penmark target $545Street high $870Price $531Street mean $633

Source: 247 Wall St, 5 Nov 2026 (mean); tickernerd, Oct 2026 (high, low); Penmark Research

Exhibit 50: 43 of 49 Street ratings are Buy and none is Sell; we are at Hold
BuyHoldSell4360

Source: MarketBeat summary, Oct 2026; 247 Wall St, 5 Nov 2026

Exhibit 51: Recent insider sales are small and pre-planned: $2.1m by the CFO under a 10b5-1 plan
Insider and dateSharesValuePlan
CFO A. Hood, 13 Oct 20262,927$1.60m10b5-1
CFO A. Hood, 13 Oct 2026991$0.54m10b5-1
EVP A. Coleman, 15 Oct 202632$0.02mTax

Source: SEC Form 4 filings, Oct 2026. After the sales Ms Hood holds 555,396 shares.

Exhibit 52: The stock trades $11.8bn a day, and the next catalyst is the 27 Jan 2027 print
Trading dataValue
Average daily traded value, 3 months$11.8bn
Market value, 6 Nov 2026$3,951bn
52-week closing range$352.83-$555.80
Days to cover, 15 Oct 20263.2
Next results27 Jan 2027

Source: Yahoo Finance (traded value, closing range, dates); FINRA; Penmark Research.

Capital allocation has shifted from returns to the build: capex is 81% of operating cash flow in FY27E, up from 27% in FY22A

Exhibit 53: Capex took 63% of operating cash flow in FY26A and takes 81% in FY27E, leaving buybacks as the swing item
Cash capex ($bn)Dividends ($bn)Buybacks ($bn)$0$100$200$300$400FY22AFY23AFY24AFY25AFY26AFY27EFY28EFY29EActualEstimates$75$70$84$107$165$222$272$314

Source: Company filings FY22A-FY26A (cash flow statement); Penmark Research model FY27E-FY29E. Cash from operations: $182.9bn FY26A, $221.5bn FY27E

Exhibit 54: Free cash flow falls to $41.1bn in FY27E, just below $42bn of payouts
$bnFY25AFY26AFY27EFY28E
Cash from operations136.2182.9221.5266.3
Cash capex64.6115.9180.4200.8
Free cash flow, reported71.667.041.165.5
Dividends24.126.428.731.0
Buybacks18.422.313.440.2
Diluted shares (m)7,4657,4537,4467,405

Source: Company filings (A); Penmark Research model (E). Buybacks offset issuance in FY27E. From FY28E the model sets buybacks above FCF after dividends ($40.2bn against $34.5bn in FY28E; about $74bn against $62bn in FY29E) and funds the gap from cash and investments.

Exhibit 55: Management beat its own FQ1 FY27 guide on revenue and Azure; all FY27 guidance is met by our forecast
FQ1 FY27 (quarter to 30 Sep 2026)GuidedReportedOutcome
Revenue$89.85-90.95bn$92.28bnAbove
Azure growth, constant currency44-45%48%Above
Cost of revenue$29.6-29.8bn$29.72bnInside
Operating expenses$16.8-16.9bn$16.64bnBelow

Source: Company outlook slides (8-K, 2 Sep 2026) and FQ1 FY27 release; Penmark Research model (Guidance). EPS has beaten estimates in nine of nine quarters (Exhibit 30).

Exhibit 56: Pay is 86% stock and the board is mostly independent; the OpenAI tie is the main related exposure
ItemFact
CEO and chairSatya Nadella; FY26 reported pay $90.6m, down 6% on FY25 ($96.5m); stock awards $77.6m
Board2025 proxy: 11 of 12 nominees independent; Sandra Peterson lead independent director
OpenAI24% stake valued at $27.46 a share; OpenAI was $10.0bn (11%) of FQ1 revenue and owes $7.2bn

Source: Microsoft 2026 proxy statement (summary); 2025 proxy statement; SEC Form 4 filings; company 10-Q FQ1 FY27; Penmark Research model.

The model: revenue compounds at 18% a year to FY29E while operating margin falls 4.8 points from FY26A

Exhibit 57: Annual model: revenue compounds at 18% a year to FY29E while operating margin falls from 46.8% to 42.0%
Years to 30 JuneFY25AFY26AFY27EFY28EFY29E
Revenue ($bn)281.7331.8395.0469.8547.2
Growth–17.8%19.0%18.9%16.5%
EBITDA ($bn)157.9193.8240.9287.5336.5
EBITDA margin56.1%58.4%61.0%61.2%61.5%
D&A ($bn)29.438.557.382.0106.8
Operating income ($bn)128.5155.2183.6205.5229.7
Operating margin45.6%46.8%46.5%43.7%42.0%
Net income ($bn)101.8133.7145.6162.2180.6
Diluted EPS ($)$13.64$17.95$19.55$21.90$24.67
Dividend per share ($)––$3.85$4.16$4.49
Cash from operations ($bn)136.2182.9221.5266.3312.3
Capex incl. finance leases ($bn)–145.3205.0223.2229.8
Free cash flow, reported ($bn)71.667.041.165.5105.5
Cash and short-term investments ($bn)–76.887.075.366.4

Source: Company filings (A); Penmark Research model (E, shaded). FY26A EPS includes OpenAI gains; forecasts exclude OpenAI results. Dash = not reported on a comparable basis.

Exhibit 58: Quarterly run-rate: FQ1 FY27 operating margin was 49.8%, but D&A has risen every quarter to $12.1bn
Fiscal quartersFQ2 25FQ3 25FQ4 25FQ1 26FQ2 26FQ3 26FQ4 26FQ1 27
Revenue ($bn)69.670.176.477.781.382.990.092.3
Growth y/y––––16.7%18.3%17.7%18.8%
Azure ($bn)17.318.520.722.424.126.029.433.2
Operating income ($bn)31.732.034.338.038.338.440.645.9
Operating margin45.5%45.7%44.9%48.9%47.1%46.3%45.1%49.8%
D&A ($bn)6.77.37.98.69.110.111.212.1
EPS excl. OpenAI ($)–$3.46–$4.13$4.14$4.27$4.74$4.89
Capex incl. leases ($bn)–––34.937.531.941.045.2
Commercial RPO ($bn)298315368392625627678677

Source: Company filings and earnings calls, FQ2 FY25 to FQ1 FY27. Quarterly D&A is as reported in each 10-Q; annual D&A in Exhibit 57 is on the restated FY26 10-K basis. Capex shown from FQ1 FY26 only; EPS excludes OpenAI results and is shown where reported on that basis.

Exhibit 59: Azure grows from 31% of revenue in FY26A to 46% in FY29E; Windows OEM and devices is the only line guided down
Revenue by product, $bnFY25AFY26AFY27EFY28EFY29EFY29E y/y
Azure72.6101.9147.3198.9252.5+27.0%
Microsoft 365 cloud84.6100.3118.4137.3156.5+14.0%
Productivity and server licensing35.437.335.434.433.7-2.0%
Industry solutions18.420.322.023.725.4+7.0%
Frontier and support services7.88.38.68.89.1+3.0%
Search and advertising22.224.827.329.832.2+8.0%
XBOX23.521.822.022.723.3+3.0%
Windows OEM and devices17.317.114.014.314.4+1.0%
Total revenue281.7331.8395.0469.8547.2+16.5%

Source: Form 8-K, 2 Sep 2026 (FY27 reporting structure, FY25A-FY26A restated); Penmark Research model (E, shaded).

Reference: every figure traces to the model, with a DCF primary method and a P/E cross-check that agree within 0.5%

Exhibit 60: Methodology: DCF to FY41 is primary, P/E is the cross-check, and the two agree within 0.5%
TopicNote
ArchetypeRecurring revenue: cloud consumption and subscriptions. Agents and Infra is 81% of FY26A revenue; Devices and Consumer, with Windows, Xbox and search, is 19%
Primary methodDCF to FY41, valued at 30 Sep 2026 and rolled to 6 Nov 2026; WACC 8.88%, terminal growth 3.0% at a 15% return on new capital
Cross-check22.55x platform-peer median on next-12-month EPS of $20.38, plus the OpenAI stake of $27.46 a share
Rejected methodsEV/FCF (FY27E FCF is near zero after finance-leased capex), EV/EBITDA (ignores capex), sum of the parts (segments share one fleet)
Rating ruleModel rule: return to value = weighted value ÷ price − 1; Buy above +10%, Sell below −10%; target = value × (1 + cost of equity − dividend yield). The disclosure page states the band on total return to target; both measures give Hold here (−5.2% and +3.5%) but can differ in sensitivities
DeparturesPeer P/E bases differ slightly by provider; consensus data predate the FQ1 FY27 print

Source: Penmark Research model (Methodology), data cut-off 8 Nov 2026; price date 6 Nov 2026. Fiscal year ends 30 June.

Exhibit 61: Reported to forecast bridge: FY26A EPS of $17.95 includes OpenAI gains; FY27E excludes them
ReconciliationFY26AFY27E
Operating income ($bn)155.2183.6
Other income, net, incl. OpenAI ($bn)10.7−1.6
Net income ($bn)133.7145.6
Diluted EPS ($)17.9519.55
Diluted shares (m)7,4537,446
Effective tax rate19.4%20.0%
Consensus EPS, excl. OpenAI ($)n/a20.02

Source: Company filings (A); Penmark Research model (E). Forecast net income excludes OpenAI investment gains and losses.

Exhibit 62: Peer set: eight companies, four of them platforms that set the 22.55x target multiple
CompanyGroupP/E (NTM)Op. margin
AlphabetPlatform17.9x31.8%
AmazonPlatform24.4x13.9%
Meta PlatformsPlatform20.7x20.1%
ApplePlatform36.1x31.1%
OracleInfrastructure12.8x30.6%*
SalesforceApplications14.2x20.5%
ServiceNowApplications22.1x9.4%
AdobeApplications9.2x36.6%*
MicrosoftPlatform24.7x49.8%

Source: Motley Fool, Zacks via Yahoo Finance (P/E, 2-6 Nov 2026); company filings, key metrics (latest quarter); Penmark Research. *Last full fiscal year from filings: Oracle FY26 (May 2026), Adobe FY25 (Nov 2025).

Exhibit 63: Data sources and as-of dates
FinancialsForm 10-K FY26 (29 Jul 2026), Form 10-Q FQ1 FY27 (28 Oct 2026), Form 8-K (2 Sep 2026), earnings calls
Prices and indexYahoo Finance closes to 6 Nov 2026; S&P 500 as index
Consensus and targetsChartmill, 247 Wall St, TIKR, tickernerd, MarketBeat, Oct to 5 Nov 2026
OwnershipSEC Form 13F (30 Jun 2026), FINRA short interest (15 Oct 2026), Form 4 insider filings (Oct 2026)
Cloud share and paySynergy Research Group (Q3 2026); Microsoft 2025 and 2026 proxy statements

Source: As listed. Model data cut-off 8 Nov 2026.

APPENDIX · DISCLOSURES

Analyst certification and important disclosures

Ratings

Ratings reflect the expected total return to our 12-month price target, including dividends, weighted across bull, base and bear scenarios.

BuyExpected total return above +10%
HoldExpected total return between −10% and +10%
SellExpected total return below −10%

We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.

Analyst certification

The Penmark Research Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.

Contact

Penmark Research

Questions about our research:
research@penmarkresearch.com

All our research and coverage:
penmarkresearch.com

Basis of preparation

This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.

Valuation and price targets

Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.

Independence and conflicts of interest

Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.

No member of the Penmark Research Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.

Regulatory status

Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.

Not investment advice or an offer

This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.

Forward-looking statements and risk

Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.

Data and sources

Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.

Accuracy and liability

Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.

Distribution and access

Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.

Copyright and permitted use

© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.

Keep reading

Sign in to Penmark